Pyrazolyl-pyrimidones inhibit the function of human solute carrier protein SLC11A2 (hDMT1) by metal chelation

Solute carrier proteins (SLCs) control fluxes of ions and molecules across biological membranes and represent an emerging class of drug targets. SLC11A2 (hDMT1) mediates intestinal iron uptake and its inhibition might be used to treat iron overload diseases such as hereditary hemochromatosis. Here w...

Descripción completa

Detalles Bibliográficos
Autores principales: Poirier, Marion, Pujol-Giménez, Jonai, Manatschal, Cristina, Bühlmann, Sven, Embaby, Ahmed, Javor, Sacha, Hediger, Matthias A., Reymond, Jean-Louis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal Society of Chemistry 2020
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649969/
https://www.ncbi.nlm.nih.gov/pubmed/33479694
http://dx.doi.org/10.1039/d0md00085j

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649969/
https://www.ncbi.nlm.nih.gov/pubmed/33479694
http://dx.doi.org/10.1039/d0md00085j

Ejemplares similares